An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis

Inflammation Research

Volumn 49, Issue 8, 2000, Pages 418-423

  Ribatti, D ^a   Vacca, A ^a   Cantatore, F P ^a   Ria, R ^a   Benagiano, V ^a   Roncali, L ^a   Dammacco, F ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Anti angiogenesis; Chorioallantoic membrane; Cyclosporine; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

ANGIOGENESIS INHIBITOR; CYCLOSPORIN A;

ANIMAL MODEL; ARTICLE; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG ACTIVITY; EMBRYO; HUMAN; HUMAN TISSUE; NONHUMAN; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIUM;

ALLANTOIS; ANIMALS; ARTHRITIS, RHEUMATOID; CHICK EMBRYO; CHORION; CYCLOSPORINE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; TIME FACTORS;

EID: 0033832657     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050610     Document Type: Article

References (42)

1. Antiangiogenesis by cyclosporine
2. Angiogenesis under normal and pathological conditions
3. Angiogenesis and inflammation
4. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
5. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues
6. Angiogenesis and rheumatoid arthritis; pathogenic and therapeutic implications
7. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease
8. Vascular permeability factor/endothelial growth factor (VPF/ VEGF): Accumulation and expression in human synovial fluid and rheumatoid synovial tissue
9. Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-β and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis
10. Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis
11. Enhanced expression of transforming growth factor beta and transforming growth factor beta-type II receptor in the synovial tissues of patients with rheumatoid arthritis
12. Expression of basic fibroblast growth factor and anngiogenin in arthritis
13. Angiogenesis inhibition suppresses collagen arthritis
14. Effects of thrombospondin-1 on disease course and angiogenesis in rat adjuvant-induced arthritis
15. 3 antagonist
16. Inhibition of human endothelial cell proliferation by gold compounds
17. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate
18. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine
19. A study of the longterm efficacy and toxicity of cyclosporine A in rheumatoid arthritis
20. Inhibition of neovascularization in vivo by gold compounds
21. Mechanisms of action of antimalarials in inflammation: Induction of apoptosis in human endothelial cells
22. Vascular turnover during carrageenan synovitis in the rat
23. Cyclosporin. A review of its pharmacodynamic and pharmacokinetics properties, and therapeutic use in immunoregolatory disorders
24. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria Committee of the American Rheumatism Association
25. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
26. 3 for angiogenesis
27. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane
28. Angiogenesis in pannus formation
29. Inhibition of production of macrophage-derived angiogenic activity by the antirheumatic agent gold sodium thiomalate and auronofin
30. Minocycline treatment of rheumatoid arthritis
31. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis
32. Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol
33. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM 1470, in combination with cyclosporin: Reduction of vascular endothelial growth factor (VEGF)
34. Modulation of angiogenic vascular endothelial growth factor (VEGF) by TNF-α and IL-1 in rheumatoid arthritis
35. Cyclosporine A inhibits polymorphonuclear leukocyte chemotaxis in vivo
36. Cellular basis for rheumatoid inflammation
37. + cells
38. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis
39. Macrophages and angiogenesis
40. Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane
41. Macrophage-induced angiogenesis is mediated by TNF-alpha
42. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane